{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T13:27:36Z","timestamp":1789133256888,"version":"build-2803163510"},"reference-count":71,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,9]]},"abstract":"<jats:sec>\n            <jats:title>Purpose of review<\/jats:title>\n            <jats:p>IL-18 is a pleiotropic cytokine involved in the regulation of innate and adaptive immune responses. IL-18 pro-inflammatory activities are finely regulated <jats:italic toggle=\"yes\">in vivo<\/jats:italic> by the inhibitory effects of the soluble IL-18-binding protein (IL-18BP). The elevation of circulating levels of IL-18 has been described in children with systemic juvenile idiopathic arthritis (sJIA). In the recent years, the role of IL-18 in the pathogenesis of secondary haemophagocytic lymphohistiocytosis (sHLH), also referred to as macrophage activation syndrome (MAS), in the context of autoinflammatory diseases, including sJIA, is emerging.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent findings<\/jats:title>\n            <jats:p>A large number of studies in patients and animal models pointed to the imbalance in IL-18\/IL-18BP levels, causing increased systemic levels of free bioactive IL-18, as a predisposing factor in the development of MAS. Although the exact mechanisms involved in the development of MAS are not clearly understood, increasing evidence demonstrate the role of IL-18 in upregulating the production of interferon (IFN)-\u03b3.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>On the basis of the first emerging data on the possibility of blocking IL-18, we here discuss the scientific rationale for neutralizing the IL-18\/IFN\u03b3 axis in the prevention and treatment of sHLH and MAS.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/bor.0000000000000634","type":"journal-article","created":{"date-parts":[[2019,6,13]],"date-time":"2019-06-13T09:02:44Z","timestamp":1560416564000},"page":"421-427","source":"Crossref","is-referenced-by-count":33,"title":["Interleukin-18 in pediatric rheumatic diseases"],"prefix":"10.1097","volume":"31","author":[{"given":"Giusi","family":"Prencipe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Bracaglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"De Benedetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230829","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.immuni.2019.03.012","article-title":"Interleukin-1 and related cytokines in the regulation of inflammation and immunity","volume":"50","author":"Mantovani","year":"2019","journal-title":"Immunity"},{"key":"R2-20230829","doi-asserted-by":"crossref","first-page":"289","DOI":"10.3389\/fimmu.2013.00289","article-title":"Interleukin-18 and IL-18 binding protein","volume":"4","author":"Dinarello","year":"2013","journal-title":"Front Immunol"},{"key":"R3-20230829","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1073\/pnas.96.5.2256","article-title":"Gene expression, synthesis, and secretion of interleukin 18 and interleukin 1beta are differentially regulated in human blood mononuclear cells and mouse spleen cells","volume":"96","author":"Puren","year":"1999","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"R4-20230829","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.cell.2010.01.040","article-title":"The inflammasomes","volume":"140","author":"Schroder","year":"2010","journal-title":"Cell"},{"key":"R5-20230829","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nature04516","article-title":"Gout-associated uric acid crystals activate the NALP3 inflammasome","volume":"440","author":"Martinon","year":"2006","journal-title":"Nature"},{"key":"R6-20230829","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1038\/ng.3089","article-title":"An activating NLRC4 inflammasome mutation causes autoinflammation with recurrent macrophage activation syndrome","volume":"46","author":"Canna","year":"2014","journal-title":"Nat Genet"},{"key":"R7-20230829","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1016\/j.cell.2015.10.048","article-title":"Microbiota-modulated metabolites shape the intestinal microenvironment by regulating NLRP6 inflammasome signaling","volume":"163","author":"Levy","year":"2015","journal-title":"Cell"},{"key":"R8-20230829","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/nature22967","article-title":"Nlrp9b inflammasome restricts rotavirus infection in intestinal epithelial cells","volume":"546","author":"Zhu","year":"2017","journal-title":"Nature"},{"key":"R9-20230829","doi-asserted-by":"crossref","first-page":"8315","DOI":"10.4049\/jimmunol.177.12.8315","article-title":"Human mast cell chymase cleaves pro-IL-18 and generates a novel and biologically active IL-18 fragment","volume":"177","author":"Omoto","year":"2006","journal-title":"J Immunol"},{"key":"R10-20230829","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1002\/eji.200535402","article-title":"Expression and alternative processing of IL-18 in human neutrophils","volume":"36","author":"Robertson","year":"2006","journal-title":"Eur J Immunol"},{"key":"R11-20230829","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/imr.12606","article-title":"The family of the interleukin-1 receptors","volume":"281","author":"Boraschi","year":"2018","journal-title":"Immunol Rev"},{"key":"R12-20230829","doi-asserted-by":"crossref","first-page":"5041","DOI":"10.4049\/jimmunol.162.9.5041","article-title":"Cutting edge: generation of IL-18 receptor-deficient mice: evidence for IL-1 receptor-related protein as an essential IL-18 binding receptor","volume":"162","author":"Hoshino","year":"1999","journal-title":"J Immunol"},{"key":"R13-20230829","doi-asserted-by":"crossref","first-page":"3759","DOI":"10.4049\/jimmunol.160.8.3759","article-title":"Differential capacities of CD4+, CD8+, and CD4-CD8- T cell subsets to express IL-18 receptor and produce IFN-gamma in response to IL-18","volume":"160","author":"Tomura","year":"1998","journal-title":"J Immunol"},{"key":"R14-20230829","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.4049\/jimmunol.167.3.1306","article-title":"An absolute requirement for STAT4 and a role for IFN-gamma as an amplifying factor in IL-12 induction of the functional IL-18 receptor complex","volume":"167","author":"Nakahira","year":"2001","journal-title":"J Immunol"},{"key":"R15-20230829","doi-asserted-by":"crossref","first-page":"4511","DOI":"10.4049\/jimmunol.162.8.4511","article-title":"Differential cytokine and chemokine gene expression by human NK cells following activation with IL-18 or IL-15 in combination with IL-12: implications for the innate immune response","volume":"162","author":"Fehniger","year":"1999","journal-title":"J Immunol"},{"key":"R16-20230829","first-page":"884","article-title":"Interleukin-18 (IL-18) synergizes with IL-2 to enhance cytotoxicity, interferon-gamma production, and expansion of natural killer cells","volume":"61","author":"Son","year":"2001","journal-title":"Cancer Res"},{"key":"R17-20230829","doi-asserted-by":"crossref","first-page":"3400","DOI":"10.4049\/jimmunol.161.7.3400","article-title":"IL-12 up-regulates IL-18 receptor expression on T cells, Th1 cells, and B cells: synergism with IL-18 for IFN-gamma production","volume":"161","author":"Yoshimoto","year":"1998","journal-title":"J Immunol"},{"key":"R18-20230829","doi-asserted-by":"crossref","first-page":"8815","DOI":"10.1073\/pnas.0402800101","article-title":"Differences in signaling pathways by IL-1beta and IL-18","volume":"101","author":"Lee","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R19-20230829","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S1074-7613(00)80013-8","article-title":"Interleukin-18 binding protein: a novel modulator of the Th1 cytokine response","volume":"10","author":"Novick","year":"1999","journal-title":"Immunity"},{"key":"R20-20230829","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1006\/bbrc.1999.2064","article-title":"Interferon-gamma mediates gene expression of IL-18 binding protein in nonleukocytic cells","volume":"267","author":"Muhl","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"key":"R21-20230829","doi-asserted-by":"crossref","first-page":"7038","DOI":"10.4049\/jimmunol.167.12.7038","article-title":"Expression and release of IL-18 binding protein in response to IFN-gamma","volume":"167","author":"Paulukat","year":"2001","journal-title":"J Immunol"},{"key":"R22-20230829","doi-asserted-by":"crossref","first-page":"16957","DOI":"10.1073\/pnas.262663399","article-title":"The promoter of IL-18 binding protein: activation by an IFN-gamma -induced complex of IFN regulatory factor 1 and CCAAT\/enhancer binding protein beta","volume":"99","author":"Hurgin","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R23-20230829","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1006\/cyto.2001.0914","article-title":"A novel IL-18BP ELISA shows elevated serum IL-18BP in sepsis and extensive decrease of free IL-18","volume":"14","author":"Novick","year":"2001","journal-title":"Cytokine"},{"key":"R24-20230829","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/ni.3103","article-title":"IL-37 requires the receptors IL-18Ralpha and IL-1R8 (SIGIRR) to carry out its multifaceted anti-inflammatory program upon innate signal transduction","volume":"16","author":"Nold-Petry","year":"2015","journal-title":"Nat Immunol"},{"key":"R25-20230829","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/imr.12605","article-title":"Suppression of inflammation and acquired immunity by IL-37","volume":"281","author":"Cavalli","year":"2018","journal-title":"Immunol Rev"},{"key":"R26-20230829","doi-asserted-by":"crossref","first-page":"4214","DOI":"10.1038\/s41598-017-04086-w","article-title":"Upregulation of circulating microRNA-134 in adult-onset Still's disease and its use as potential biomarker","volume":"7","author":"Liao","year":"2017","journal-title":"Sci Rep"},{"key":"R27-20230829","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1128\/iai.57.2.590-595.1989","article-title":"Endotoxin-induced serum factor that stimulates gamma interferon production","volume":"57","author":"Nakamura","year":"1989","journal-title":"Infection Immunity"},{"key":"R28-20230829","doi-asserted-by":"crossref","first-page":"5464","DOI":"10.4049\/jimmunol.170.11.5464","article-title":"IL-21 in synergy with IL-15 or IL-18 enhances IFN-gamma production in human NK and T cells","volume":"170","author":"Strengell","year":"2003","journal-title":"J Immunol"},{"key":"R29-20230829","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1084\/jem.187.12.2103","article-title":"Murine macrophages secrete interferon gamma upon combined stimulation with interleukin (IL)-12 and IL-18: a novel pathway of autocrine macrophage activation","volume":"187","author":"Munder","year":"1998","journal-title":"J Exp Med"},{"key":"R30-20230829","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.4049\/jimmunol.166.5.3075","article-title":"The production of IFN-gamma by IL-12\/IL-18-activated macrophages requires STAT4 signaling and is inhibited by IL-4","volume":"166","author":"Schindler","year":"2001","journal-title":"J Immunol"},{"key":"R31-20230829","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1093\/intimm\/12.2.151","article-title":"IL-12 synergizes with IL-18 or IL-1beta for IFN-gamma production from human T cells","volume":"12","author":"Tominaga","year":"2000","journal-title":"Int Immunol"},{"key":"R32-20230829","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.3389\/fimmu.2017.01959","article-title":"Interleukin (IL)-23 stimulates IFN-gamma secretion by CD56(bright) natural killer cells and enhances IL-18-driven dendritic cells activation","volume":"8","author":"Ziblat","year":"2017","journal-title":"Front Immunol"},{"key":"R33-20230829","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1016\/j.cell.2015.10.072","article-title":"Epithelial IL-18 equilibrium controls barrier function in colitis","volume":"163","author":"Nowarski","year":"2015","journal-title":"Cell"},{"key":"R34-20230829","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.cytogfr.2014.05.005","article-title":"Cytokine balance and cytokine-driven natural killer cell dysfunction in systemic juvenile idiopathic arthritis","volume":"26","author":"Avau","year":"2015","journal-title":"Cytokine Growth Factor Rev"},{"key":"R35-20230829","first-page":"823","article-title":"Interleukin 18 as a marker of disease activity and severity in patients with juvenile idiopathic arthritis","volume":"34","author":"Lotito","year":"2007","journal-title":"J Rheumatol"},{"key":"R36-20230829","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1007\/s10067-006-0474-0","article-title":"Interleukin-18 as a mediator of systemic juvenile idiopathic arthritis","volume":"26","author":"Jelusic","year":"2007","journal-title":"Clin Rheumatol"},{"key":"R37-20230829","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.3899\/jrheum.140025","article-title":"Serum interleukin 18 as a diagnostic remission criterion in systemic juvenile idiopathic arthritis","volume":"41","author":"Shimizu","year":"2014","journal-title":"J Rheumatol"},{"key":"R38-20230829","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1136\/ard.2006.061853","article-title":"Blood and synovial fluid cytokine signatures in patients with juvenile idiopathic arthritis: a cross-sectional study","volume":"66","author":"de Jager","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"R39-20230829","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1136\/ard.2003.016428","article-title":"Synovial tissue interleukin-18 expression and the response to treatment in patients with inflammatory arthritis","volume":"63","author":"Rooney","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"R40-20230829","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s41927-019-0053-z","article-title":"Comparative study of Interleukin-18 (IL-18) serum levels in adult onset Still's disease (AOSD) and systemic onset juvenile idiopathic arthritis (sJIA) and its use as a biomarker for diagnosis and evaluation of disease activity","volume":"3","author":"Kudela","year":"2019","journal-title":"BMC Rheumatol"},{"key":"R41-20230829","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1093\/rheumatology\/keq133","article-title":"Distinct cytokine profiles of systemic-onset juvenile idiopathic arthritis-associated macrophage activation syndrome with particular emphasis on the role of interleukin-18 in its pathogenesis","volume":"49","author":"Shimizu","year":"2010","journal-title":"Rheumatology (Oxford, England)"},{"key":"R42-20230829","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1182\/blood-2017-12-820852","article-title":"Interleukin-18 diagnostically distinguishes and pathogenically promotes human and murine macrophage activation syndrome","volume":"131","author":"Weiss","year":"2018","journal-title":"Blood"},{"key":"R43-20230829","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12969-016-0130-4","article-title":"Syndrome: different mechanisms leading to a one clinical syndrome","volume":"15","author":"Bracaglia","year":"2017","journal-title":"Pediatr Rheumatol Online J"},{"key":"R44-20230829","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/bjh.14147","article-title":"Advances in the pathogenesis of primary and secondary haemophagocytic lymphohistiocytosis: differences and similarities","volume":"174","author":"Brisse","year":"2016","journal-title":"Br J Haematol"},{"key":"R45-20230829","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.clim.2015.06.005","article-title":"Interleukin-18 for predicting the development of macrophage activation syndrome in systemic juvenile idiopathic arthritis","volume":"160","author":"Shimizu","year":"2015","journal-title":"Clin Immunol"},{"key":"R46-20230829","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1038\/ng.3066","article-title":"Mutation of NLRC4 causes a syndrome of enterocolitis and autoinflammation","volume":"46","author":"Romberg","year":"2014","journal-title":"Nat Genet"},{"key":"R47-20230829","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s10875-015-0141-9","article-title":"X-linked inhibitor of apoptosis protein deficiency: more than an X-linked lymphoproliferative syndrome","volume":"35","author":"Aguilar","year":"2015","journal-title":"J Clin Immunol"},{"key":"R48-20230829","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.cyto.2013.09.007","article-title":"Sustained elevation of serum interleukin-18 and its association with hemophagocytic lymphohistiocytosis in XIAP deficiency","volume":"65","author":"Wada","year":"2014","journal-title":"Cytokine"},{"key":"R49-20230829","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1136\/adc.81.2.179","article-title":"High IL-18 (interferon-gamma inducing factor) concentration in a purine nucleoside phosphorylase deficient patient","volume":"81","author":"Yamamoto","year":"1999","journal-title":"Arch Dis Child"},{"key":"R50-20230829","doi-asserted-by":"crossref","first-page":"3486","DOI":"10.1002\/art.38793","article-title":"Whole-exome sequencing reveals overlap between macrophage activation syndrome in systemic juvenile idiopathic arthritis and familial hemophagocytic lymphohistiocytosis","volume":"66","author":"Kaufman","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"R51-20230829","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1093\/rheumatology\/kep418","article-title":"Mutations in the perforin gene can be linked to macrophage activation syndrome in patients with systemic onset juvenile idiopathic arthritis","volume":"49","author":"Vastert","year":"2010","journal-title":"Rheumatology"},{"key":"R52-20230829","doi-asserted-by":"crossref","first-page":"5999","DOI":"10.1128\/JVI.02350-08","article-title":"Potential role of interleukin-18 in the immunopathogenesis of AIDS: involvement in fratricidal killing of NK cells","volume":"83","author":"Iannello","year":"2009","journal-title":"J Virol"},{"key":"R53-20230829","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1002\/1529-0131(200104)44:4<884::AID-ANR145>3.0.CO;2-4","article-title":"A novel role for interleukin-18 in human natural killer cell death: high serum levels and low natural killer cell numbers in patients with systemic autoimmune diseases","volume":"44","author":"Shibatomi","year":"2001","journal-title":"Arthritis Rheum"},{"key":"R54-20230829","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1002\/art.24750","article-title":"Defective phosphorylation of interleukin-18 receptor beta causes impaired natural killer cell function in systemic-onset juvenile idiopathic arthritis","volume":"60","author":"de Jager","year":"2009","journal-title":"Arthritis Rheum"},{"key":"R55-20230829","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1172\/JCI43157","article-title":"Repeated TLR9 stimulation results in macrophage activation syndrome-like disease in mice","volume":"121","author":"Behrens","year":"2011","journal-title":"J Clin Invest"},{"key":"R56-20230829","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1182\/blood-2017-06-789552","article-title":"Unopposed IL-18 signaling leads to severe TLR9-induced macrophage activation syndrome in mice","volume":"131","author":"Girard-Guyonvarc\u2019h","year":"2018","journal-title":"Blood"},{"key":"R57-20230829","doi-asserted-by":"crossref","first-page":"3483","DOI":"10.1182\/blood-2005-05-1980","article-title":"Severe imbalance of IL-18\/IL-18BP in patients with secondary hemophagocytic syndrome","volume":"106","author":"Mazodier","year":"2005","journal-title":"Blood"},{"key":"R58-20230829","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/imr.12607","article-title":"The NLRC4 Inflammasome","volume":"281","author":"Duncan","year":"2018","journal-title":"Immunol Rev"},{"key":"R59-20230829","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.clim.2017.04.007","article-title":"Hemophagocytic lymphohistiocytosis with high serum levels of IL-18 and predominant lymphocyte activation in a neonate born to a mother with adult-onset Still's disease","volume":"180","author":"Hashimoto","year":"2017","journal-title":"Clin Immunol"},{"key":"R60-20230829","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V126.23.LBA-3.LBA-3","article-title":"A novel targeted approach to the treatment of hemophagocytic lymphohistiocytosis (HLH) with an anti-interferon gamma (IFN\u03b3) monoclonal antibody (mAb), NI-0501: first results from a pilot phase 2 study in children with primary HLH","volume":"126","author":"Jordan","year":"2015","journal-title":"Blood"},{"key":"R61-20230829","doi-asserted-by":"crossref","first-page":"3769","DOI":"10.4049\/jimmunol.1701628","article-title":"Deletion of inflammasome components is not sufficient to prevent fatal inflammation in models of familial hemophagocytic lymphohistiocytosis","volume":"200","author":"Fauteux-Daniel","year":"2018","journal-title":"J Immunol"},{"key":"R62-20230829","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1136\/annrheumdis-2015-209020","article-title":"Elevated circulating levels of interferon-gamma and interferon-gamma-induced chemokines characterise patients with macrophage activation syndrome complicating systemic juvenile idiopathic arthritis","volume":"76","author":"Bracaglia","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"R63-20230829","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/j.jaci.2017.07.021","article-title":"Neutralization of IFN-gamma reverts clinical and laboratory features in a mouse model of macrophage activation syndrome","volume":"141","author":"Prencipe","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"R64-20230829","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1016\/j.jaci.2016.10.022","article-title":"Life-threatening NLRC4-associated hyperinflammation successfully treated with IL-18 inhibition","volume":"139","author":"Canna","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"R65-20230829","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1093\/rheumatology\/keu524","article-title":"Cytokines in systemic juvenile idiopathic arthritis and haemophagocytic lymphohistiocytosis: tipping the balance between interleukin-18 and interferon-gamma","volume":"54","author":"Put","year":"2015","journal-title":"Rheumatology"},{"key":"R66-20230829","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.cyto.2019.03.018","article-title":"Clinical significance of serum CXCL9 levels as a biomarker for systemic juvenile idiopathic arthritis associated macrophage activation syndrome","volume":"119","author":"Mizuta","year":"2019","journal-title":"Cytokine"},{"key":"R67-20230829","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/nrrheum.2015.179","article-title":"Macrophage activation syndrome in the era of biologic therapy","volume":"12","author":"Grom","year":"2016","journal-title":"Nat Rev Rheumatol"},{"key":"R68-20230829","first-page":"840","article-title":"Open-label, multicentre, dose-escalating phase II clinical trial on the safety and efficacy of tadekinig alfa (IL-18BP) in adult-onset Still's disease","volume":"77","author":"Gabay","year":"2018","journal-title":"Ann Rheum Dis"},{"issue":"(Suppl 10)","key":"R69-20230829","article-title":"Emapalumab, an anti-interferon gamma monoclonal antibody in two patients with NLRC4-related disease and severe hemophagocytic lymphohistiocytosis (HLH) [abstract]","volume":"70","author":"Bracaglia","year":"2018","journal-title":"Arthritis Rheumatol"},{"key":"R70-20230829","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1186\/s12967-018-1655-8","article-title":"Plasma interleukin-37 is increased and inhibits the production of inflammatory cytokines in peripheral blood mononuclear cells in systemic juvenile idiopathic arthritis patients","volume":"16","author":"Feng","year":"2018","journal-title":"J translational Med"},{"key":"R71-20230829","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.4049\/jimmunol.170.4.2100","article-title":"Mechanisms of inhibition of collagen-induced arthritis by murine IL-18 binding protein","volume":"170","author":"Banda","year":"2003","journal-title":"J Immunol"}],"container-title":["Current Opinion in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/BOR.0000000000000634","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,29]],"date-time":"2023-08-29T07:06:57Z","timestamp":1693292817000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/BOR.0000000000000634"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":71,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/bor.0000000000000634","relation":{},"ISSN":["1040-8711","1531-6963"],"issn-type":[{"value":"1040-8711","type":"print"},{"value":"1531-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9]]}}}